Pictet Asset Management Holding SA

Position in ABBV — AbbVie Inc.

CIK 1993888 CAROUGE, V8

Position in ABBV

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$255,274,320

-$7,198,083 QoQ

Shares Held

1,173,729

+2.2% QoQ

Ownership

0.066%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 66.98190127363301.ToString("F0")% Shared 0.ToString("F0")% None 33.01809872636699.ToString("F0")%

Healthcare · as of Mar 31, 2026

Pictet Asset Management Holding SA holds $3,378,373,394 across 13 Drug Manufacturers - General names. ABBV ranks #6 (7.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	943,976	$868,240,805
2	AZN	Astrazeneca PLC	3,481,864	$686,693,218
3	GILD	Gilead Sciences, Inc.	2,574,822	$358,852,942
4	JNJ	Johnson & Johnson	1,460,529	$357,011,708
5	AMGN	Amgen Inc	830,595	$292,244,850
6	ABBV	AbbVie Inc. This page	1,173,729	$255,274,320
7	MRK	Merck & Co., Inc.	1,486,425	$178,802,063
8	BIIB	Biogen Inc.	913,328	$167,440,422

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$255,274,320	1,173,729	+2.2%	Shares	Sole	2026-04-22
2025-12-31	$262,472,403	1,148,726	+10.1%	Shares	Sole	2026-01-29
2025-09-30	$241,558,272	1,043,268	+0.5%	Shares	Sole	2025-11-18
2025-06-30	$192,762,843	1,038,481	+18.6%	Shares	Sole	2025-08-13
2025-03-31	$183,450,474	875,575	+7.1%	Shares	Sole	2025-05-05
2024-12-31	$145,250,025	817,389	+3.4%	Shares	Sole	2025-02-12
2024-09-30	$156,131,242	790,618	-0.3%	Shares	Sole	2024-11-12
2024-06-30	$136,054,809	793,230	-7.4%	Shares	Sole	2024-08-13
2024-03-31	$156,062,613	857,016	-9.6%	Shares	Sole	2024-05-14
2023-12-31	$146,940,849	948,189	+3.4%	Shares	Sole	2024-02-13
2023-09-30	$136,652,096	916,759	—	Shares	Sole	2023-11-14
No filing history on record for this holder in this stock.